Your institution may have access to this item. Find your institution then sign in to continue.
Title
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.
Authors
Held LA; Rizzieri D; Long GD; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Horwitz ME; Chao NJ; Gasparetto C